Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 May 2023 | Story EDZANI NEPHALELA | Photo Supplied

The University of the Free State (UFS), in collaboration with the Department of Science and Innovation (DSI), South African Centre for Digital Language Resources (SADiLaR), Council for Scientific and Industrial Research (CSIR), and Universities South Africa (USAf), will be conducting its Language Resource Audit for the UFS on 2 June 2023. 

This audit process will assess the resources available and required for the implementation of a Language policy framework for higher education (2020) – such as the development of multilingual terminologies, translation services for teaching and learning materials, campus signage, as well as various multimedia collateral – including their quality and relevance to the needs of the students and faculty. The audit will include an assessment of existing resources and whether they are furthering implementation goals, and may also include the gathering of feedback from students and faculty to identify improvement areas.

Dr Nomalungelo Ngubane, Director of the UFS Academy for Multilingualism, said the process will help the UFS identify the essential languages resources that are available for the successful implementation of the 2020 Language Policy for Higher Education framework (LPHE). “The audit will identify how much has been done at the UFS and which institutions we can collaborate with, for example, in the development of Sesotho, so that we do not reinvent the wheel, but we close the gaps.” 

Once the audit is completed, the institution will develop a plan for resource allocation to address the identified gaps. This may involve acquiring new resources, upgrading existing ones, or reallocating existing resources better to meet the needs of students, staff, and faculties.

Due to the impact this audit will have on various stakeholders, all staff and students are encouraged to participate. To attend the audit, please RSVP here by 30 May 2023.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept